Transformation in Trials
A podcast about the transformations in clinical trial. As life science companies are pressured to deliver novel drugs faster, data, processes, applications, roles and change itself is changing. We speak to people in the industry that experience these transformations up close and make sense of how the pressure can become a catalyst for transformation.
Transformation in Trials
Transformation in science, data and roles
Sam and Ivanna speak to Angela Slocum about the difficulty in quantifying the benefits of risk based monitoring when mostly you find no issues in your data. Angela does share an example of a fraudulent site being uncovered through risk based monitoring. We speak about how having experience from multiple clinical functions enables a unique platform for innovation when new demands arise but also when implementing software in the clinical space. We also dwell on managing change in our industry, and how conquering fear is vital even when working with highly skilled experts.
“The science is so much more sophisticated than it used to be. There is much more data than there used to be. The data types and the amount of data are vast. And the roles and skills needed to support all that have evolved”
- Angela Slocum
Notes
Guest Angela Slocum: https://www.linkedin.com/in/angela-slocum-160b48126/
Risk-based monitoring (TransCelerate): https://www.transceleratebiopharmainc.com/rbminteractiveguide/what-is-risk-based-monitoring-rbm/introduction/
Technology mentioned:
- SAS
- JReview
- Spotfire
- EDC
- AI/ ML
- elluminate
Functions mentioned:
- Statistical Programming
- Data Management
- Clinical Operations
- Analytics
________
Reach out to Ivanna Rosendal
Join the conversation on our LinkedIn page
.png)